Cancer Detection and Diagnosis Research — CFDA 93.394

Detection-research obligations at $4.05 billion

USAspending.gov records $4,051,456,547.91 in obligations under CFDA 93.394. One thousand eight hundred seventy-five awards produce that stock. A simple average is about $2.16 million per award — typical of multi-year biomedical research grants rather than state block grants. That average is a quotient of two packet totals, not a typical imaging-study budget.

The assistance-listing title is CANCER DETECTION AND DIAGNOSIS RESEARCH. CFDA 93.394 is the identifier. Treatment, biology, and centers listings are separate CFDA numbers and are not mixed into the $4.05 billion. Combining those codes would invent a combined cancer-research total this packet does not contain.

417 recipients, 45-state coding

Four hundred seventeen recipients share 1,875 awards, or about 4.5 award records per recipient on average. Splitting $4.05 billion evenly would assign about $9.7 million per recipient. That pattern matches a research portfolio in which institutions hold several concurrent awards. The packet does not list the 417. Recipient count is the organizational headcount, not a census of investigators or patients.

Forty-five states in the geographic count show broad coding without covering every coded jurisdiction. Research dollars still concentrate at large biomedical campuses. The state count does not flatten those differences. Place-of-performance amounts are on the program table.

Award count is not a screening count

Among cancer-research listings, 93.394 is a mid-density file: 1,875 rows against 417 recipients. Renewals and supplements can inflate award count relative to unique projects. Award count is therefore a weak proxy for “number of detection studies.” Recipients (417) tell you how many named organizations sit on the extract; awards (1,875) tell you how many assistance rows were stored.

The packet does not report screens performed, diagnostic accuracy, or publication counts. Citing 1,875 as patients or tests would be a unit error. Keep the units straight: dollars, awards, recipients, states.

Obligations versus research outlays

The $4.05 billion is an obligation total from USAspending.gov. Outlays — cash paid against detection-research awards — are not in the packet. A laboratory can show a large obligation stock while draws follow a multi-year grant calendar. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.394 to size the Cancer Detection and Diagnosis Research listing in the assistance file. Do not use it as a screening-outcomes dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.394.

What the 93.394 tables omit

The Cancer Detection and Diagnosis Research hub lists award-backed obligations from USAspending.gov. It is not a trial registry, not a patient census, and not a publication index. Series that never appear as assistance awards will not show up in the $4,051,456,547.91. That omission is definitional rather than a gap in the 1,875 award rows.

Place-of-performance on 45 states is a coding field. Read the program page before treating those cells as equal shares. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already spent on assays or staff.

Where the 93.394 table lives

The Cancer Detection and Diagnosis Research program page overlays these four facts. The all-programs index ranks 93.394 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other cancer-research listings. For 93.394 only, start on the program page.

CFDA 93.394’s 1,875 awards spread $4,051,456,547.91 across 417 recipients and 45 states. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 4.5 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards.

CFDA 93.394 is indexed at $4,051,456,547.91 in obligations, 1,875 awards, 417 recipients, and 45 states on USAspending.gov. Cancer Detection and Diagnosis Research should be cited on that CFDA row alone. The $4.05 billion figure sizes the listing in the assistance file. It does not convert obligations into outlays, and it does not convert award count into a service, patient, student, or project census.

Readers who need the overlay tables should start on the program page for CFDA 93.394, then rank the listing on the all-programs index. Agency pages show awarding-agency rollups that may include this CFDA among other listings; they do not replace the $4,051,456,547.91 obligation stock. Keep the four facts together when quoting Cancer Detection and Diagnosis Research: dollars as obligations from USAspending.gov, award count as a stored-row count, recipient count as the organizational headcount (including 0 when the extract stores none), and the state figure as a geographic coding count.

Questions

How much is obligated for cancer detection and diagnosis research?

USAspending.gov records $4,051,456,547.91 in obligations for CFDA 93.394. SpendingVault indexes 1,875 awards, 417 recipients, and 45 states. The figure is an obligation sum from assistance awards, not an outlay and not a patient count. CFDA 93.394’s $4.05 billion is the USAspending obligation stock.

How many awards does CFDA 93.394 carry?

The listing shows 1,875 awards against 417 recipients, or about 4.5 award records per recipient. A simple average is about $2.16 million per award. Award count is not a screening or patient count. Recipient dollars are on the program page.

How many organizations receive 93.394 awards?

The extract lists 417 recipients. Those are organizational recipients on assistance awards tagged 93.394. Geographic coding covers 45 states. The packet does not name the 417 or publish scientific output. Recipient count is the organizational headcount. CFDA 93.394’s $4.05 billion on 1,875 awards, with 417 recipients and 45 states in this aggregate, is the USAspending obligation stock.

Is $4.05 billion already spent on detection research?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.394’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or research results. The $4.05 billion on 1,875 awards is the obligation figure.